Despite this success, investors were unimpressed with the topline data, with Syndax’s stock dropping by 25.6%, from $21.78 ...

Medical advances and better knowledge of health have contributed to increased life expectancy and a growing elderly ...

They say lightning rarely strikes twice but Kezar Life Sciences has suffered its second clinical blow in as many months.

At two upcoming events on rare disease clinical trials and data management, experts will dissect the latest trends and ...

Lyophilization plays a crucial role in successful biologic molecule development, but what is lyophilization – and how can it ...